223 related articles for article (PubMed ID: 17949576)
1. [Low dose estrogens and synthetic estrogens. Options for hormone replacement therapy in climacteric women].
Velasco-Murillo V
Rev Med Inst Mex Seguro Soc; 2007; 45(4):381-7. PubMed ID: 17949576
[TBL] [Abstract][Full Text] [Related]
2. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
Crandall C
J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
[TBL] [Abstract][Full Text] [Related]
3. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
6. [Estrogen treatment in climacteric and postmenopause after 2002. Can it still be prescribed?].
Velasco-Murillo V
Rev Med Inst Mex Seguro Soc; 2006; 44(1):61-9. PubMed ID: 16497260
[TBL] [Abstract][Full Text] [Related]
7. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
Antoine C; Ameye L; Paesmans M; Rozenberg S
Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal osteoporosis and hormone replacement therapy.
Gambacciani M; Vacca F
Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
[TBL] [Abstract][Full Text] [Related]
9. [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico].
Velasco-Murillo V
Gac Med Mex; 2001; 137(3):237-42. PubMed ID: 11432092
[TBL] [Abstract][Full Text] [Related]
10. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
11. Estrogen therapy of perimenopausal and postmenopausal patients.
Magera BE; Amerson AB; Wilson E
Am J Hosp Pharm; 1979 Aug; 36(8):1062-71. PubMed ID: 384786
[No Abstract] [Full Text] [Related]
12. Hormone replacement therapy in postmenopausal women.
Prelevic GM; Kocjan T; Markou A
Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
[TBL] [Abstract][Full Text] [Related]
13. [Low-dose estrogens in the treatment of the climacteric syndrome].
Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
Peeyananjarassri K; Baber R
Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
[TBL] [Abstract][Full Text] [Related]
16. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
17. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
[TBL] [Abstract][Full Text] [Related]
18. [Risks, benefits and costs of hormone replacement therapy in menopause].
Gaspard U
Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
[TBL] [Abstract][Full Text] [Related]
19. Improvement of skin surface texture by topical estradiol treatment in climacteric women.
Masuda Y; Hirao T; Mizunuma H
J Dermatolog Treat; 2013 Aug; 24(4):312-7. PubMed ID: 22103800
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the dose of hormone replacement therapy.
Rice VM
Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
